10.42 USD
+0.46 (+4.62%)
At close: Feb 6, 2026
10.42 USD
0 (0%)
After Hours: 2/6/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 87% to ORIC. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 21.42. This target is 105.57% above the current price.
- ORIC was analyzed by 20 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ORIC.
- In the previous month the buy percentage consensus was at a similar level.
- ORIC was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2026-01-07 | Piper Sandler | Initiate | Overweight |
| 2025-12-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-12-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-20 | Evercore ISI Group | Initiate | Outperform |
| 2025-11-18 | Wolfe Research | Initiate | Peer Perform |
| 2025-11-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-17 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-13 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-07-08 | Ladenburg Thalmann | Initiate | Buy |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
ORIC PHARMACEUTICALS INC / ORIC FAQ
What do analysts expect the price target to be for ORIC PHARMACEUTICALS INC (ORIC)?
20 analysts have analysed ORIC and the average price target is 21.42 USD. This implies a price increase of 105.57% is expected in the next year compared to the current price of 10.42.
How do analysts rate ORIC PHARMACEUTICALS INC (ORIC)?
The consensus rating for ORIC PHARMACEUTICALS INC (ORIC) is 87 / 100 . This indicates that analysts generally have a positive outlook on the stock.